Mercer Global Advisors
IMNM icon

Mercer Global Advisors’s Immunome IMNM Stock Holding History

Mercer Global Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.1K Buy
+1,988
New +$42.5K ﹤0.01% 4405

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

Mercer Global Advisors's IMNM Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Immunome (IMNM) in Q2 2026: 1,988 shares worth $42.1K. The stake represents ﹤0.01% of the portfolio and ranks #4405 among its holdings.

188 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Mercer Global Advisors held 1,988 shares of Immunome worth $42.1K as of Q2 2026.
  • Immunome was a new Mercer Global Advisors position in Q2 2026.
  • Immunome made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #4405 holding.
  • 188 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.